NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines
Greater Glasgow and Clyde Medicines
For all prescribers and health professionals both in primary care and the acute sector.
All editions of PostScript (the previous name for Medicines Update) from 2011 onwards have been added to this site. Click here for an index to all previous editions. If you would like a copy of a previous edition, please contact medicines.update@ggc.scot.nhs.uk
Posted: February 20, 2018.
Category - Medicines Update
There have been recent incidents across GG&C involving 48 hourly IV gentamicin which was prescribed a day in advance and subsequently administered 24 hours earlier than intended. This may potentially lead to gentamicin toxicity ...
Posted: February 19, 2018.
Category - Medicines Update
The NHSGGC Guideline on Orthopaedic Thromboprophylaxis for Patients Admitted to Hospital has been reviewed and updated. This is now available on the Clinical Guideline Repository on Staffnet
Posted: February 19, 2018.
Category - Medicines Update
Our NEW Medicine Supply Pro...
Posted: February 19, 2018.
Category - Medicines Update
Key points SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin noradrenaline reuptake inhibitors) are associated with a risk of bleeding, especially upper GI bleedingThe risk of GI bleeding ...
Posted: February 19, 2018.
Category - Medicines Update
Key messages: Lithium is a gold standard treatment for maintenance treatment of bipolar affective disorder Lithium has a high potential for toxicity and requires careful monitoring to ensure its safe and...
Posted: January 29, 2018.
Category - Medicines Update
The Therapeutics Handbook content has now been updated and includes the following main changes: Drug Overdose and Toxicity
Posted: January 19, 2018.
Category - Medicines Update
The NHSGGC Antimicrobial Management Team have published guidance on the use of antivirals for influenza. This guidance includes a link to the Public Health England guidance which has been approved for use in Scotland by the Scottish Health...
Posted: January 19, 2018.
Category - Medicines Update
The following is a message from Yellow Card Scotland: ‘’The Yellow Card (YC) reporting data for Scotland for the Year 2016-17 is now available in our
Posted: January 19, 2018.
Category - Medicines Update
LHRH agonists have an important role in the management of prostate cancer. Within NHSGGC, leuprorelin (Prostap® DCS brand) is the medicine of choice for new patients where castration therapy with an LHRH agonist i...
Posted: January 19, 2018.
Category - Medicines Update
Key messages Eplerenone and spironolactone are mineralocorticoid receptor antagonists (MRAs) Combining ACEI (or ARB) with MRA in patients with HF due to reduced LVEF improves major outcomes C...